OBJECTIVE: To test the hypothesis that an altered gut microbiota (dysbiosis) plays a role in obesity-associated osteoarthritis (OA). METHODS: Stool and blood samples were collected from 92 participants with a body mass index (BMI) ≥30 kg/m2 , recruited from the Johnston County Osteoarthritis Project. OA patients (n = 50) had hand and knee OA (Kellgren/Lawrence [K/L] grade ≥2 or arthroplasty). Controls (n = 42) had no hand OA and a K/L grade of 0-1 for the knees. Compositional analysis of stool samples was carried out by 16S ribosomal RNA amplicon sequencing. Alpha- and beta-diversity and differences in taxa relative abundances were determined. Blood samples were used for multiplex cytokine analysis and measures of lipopolysaccharide (LPS) and LPS binding protein. Germ-free mice were gavaged with patient- or control-pooled fecal samples and fed a 40% fat, high-sucrose diet for 40 weeks. Knee OA was evaluated histologically. RESULTS: On average, OA patients were slightly older than the controls, consisted of more women, and had a higher mean BMI, higher mean Western Ontario and McMaster Universities Osteoarthritis Index pain score, and higher mean K/L grade. There were no significant differences in α- or β-diversity or genus level composition between patients and controls. Patients had higher plasma levels of osteopontin (P = 0.01) and serum LPS (P < 0.0001) compared to controls. Mice transplanted with patient or control microbiota exhibited a significant difference in α-diversity (P = 0.02) and β-diversity, but no differences in OA severity were observed. CONCLUSION: The lack of differences in the gut microbiota, but increased serum LPS levels, suggest the possibility that increased intestinal permeability allowing for greater absorption of LPS, rather than a dysbiotic microbiota, may contribute to the development of OA associated with obesity.
OBJECTIVE: To test the hypothesis that an altered gut microbiota (dysbiosis) plays a role in obesity-associated osteoarthritis (OA). METHODS: Stool and blood samples were collected from 92 participants with a body mass index (BMI) ≥30 kg/m2 , recruited from the Johnston County Osteoarthritis Project. OA patients (n = 50) had hand and knee OA (Kellgren/Lawrence [K/L] grade ≥2 or arthroplasty). Controls (n = 42) had no hand OA and a K/L grade of 0-1 for the knees. Compositional analysis of stool samples was carried out by 16S ribosomal RNA amplicon sequencing. Alpha- and beta-diversity and differences in taxa relative abundances were determined. Blood samples were used for multiplex cytokine analysis and measures of lipopolysaccharide (LPS) and LPS binding protein. Germ-free mice were gavaged with patient- or control-pooled fecal samples and fed a 40% fat, high-sucrose diet for 40 weeks. Knee OA was evaluated histologically. RESULTS: On average, OA patients were slightly older than the controls, consisted of more women, and had a higher mean BMI, higher mean Western Ontario and McMaster Universities Osteoarthritis Index pain score, and higher mean K/L grade. There were no significant differences in α- or β-diversity or genus level composition between patients and controls. Patients had higher plasma levels of osteopontin (P = 0.01) and serum LPS (P < 0.0001) compared to controls. Mice transplanted with patient or control microbiota exhibited a significant difference in α-diversity (P = 0.02) and β-diversity, but no differences in OA severity were observed. CONCLUSION: The lack of differences in the gut microbiota, but increased serum LPS levels, suggest the possibility that increased intestinal permeability allowing for greater absorption of LPS, rather than a dysbiotic microbiota, may contribute to the development of OA associated with obesity.
Authors: M Andrea Azcarate-Peril; Natasha Butz; Maria Belen Cadenas; Matthew Koci; Anne Ballou; Mary Mendoza; Rizwana Ali; Hosni Hassan Journal: Appl Environ Microbiol Date: 2018-02-14 Impact factor: 4.792
Authors: Zachary A Scherzer; Carolina Alvarez; Jordan B Renner; Louise B Murphy; Todd A Schwartz; Joanne M Jordan; Yvonne M Golightly; Amanda E Nelson Journal: J Rheumatol Date: 2020-02-15 Impact factor: 4.666
Authors: Richard F Loeser; Kathryn L Kelley; Alexandra Armstrong; John A Collins; Brian O Diekman; Cathy S Carlson Journal: Arthritis Rheumatol Date: 2020-08-26 Impact factor: 10.995
Authors: A Willemien Visser; Andreea Ioan-Facsinay; Renée de Mutsert; Ralph L Widya; Marieke Loef; Albert de Roos; Saskia le Cessie; Martin den Heijer; Frits R Rosendaal; Margreet Kloppenburg Journal: Arthritis Res Ther Date: 2014-01-22 Impact factor: 5.156
Authors: Cindy G Boer; Djawad Radjabzadeh; Carolina Medina-Gomez; Sanzhima Garmaeva; Dieuwke Schiphof; Pascal Arp; Thomas Koet; Alexander Kurilshikov; Jingyuan Fu; M Arfan Ikram; Sita Bierma-Zeinstra; André G Uitterlinden; Robert Kraaij; Alexandra Zhernakova; Joyce B J van Meurs Journal: Nat Commun Date: 2019-10-25 Impact factor: 14.919
Authors: B R Rushing; S McRitchie; L Arbeeva; A E Nelson; M A Azcarate-Peril; Y-Y Li; Y Qian; W Pathmasiri; S C J Sumner; R F Loeser Journal: Osteoarthritis Cartilage Date: 2021-10-28 Impact factor: 6.576